Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
United Therapeutics (UTHR) has provided an announcement.
At the 2024 Annual Meeting of Shareholders, all director nominees were elected with a clear majority, with Jan Malcolm receiving the highest support. Shareholders also approved executive compensation, the restatement of the stock incentive plan, and the appointment of Ernst & Young as the public accounting firm. This demonstrates strong shareholder confidence in the company’s governance and strategic financial decisions.
See more data about UTHR stock on TipRanks’ Stock Analysis page.
